These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2748555)

  • 21. [The efficacy of antioxidant therapy in patients with tuberculosis of the lungs and the correction of lipid peroxidation processes].
    Safarian MD; Karagezian KG; Karapetian ET; Avanesian NA
    Probl Tuberk; 1990; (5):40-4. PubMed ID: 2388892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental basis for the use of antioxidants in tuberculosis].
    Gurieva IG; Andrzheiuk NI; Smirnova NA; Elistratova NA; Novoselova VP
    Probl Tuberk; 1984 Apr; (4):59-64. PubMed ID: 6739464
    [No Abstract]   [Full Text] [Related]  

  • 23. [Physiotherapy in combined treatment of patients with genital tuberculosis].
    Sokolova VS; Zhuchenko OG; Ivanova TI; Gulua IR; Aĭdamirova RM
    Vopr Kurortol Fizioter Lech Fiz Kult; 2004; (6):32-3. PubMed ID: 15717538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mononeuropathy multiplex and chylothorax as earlier manifestations of pulmonary tuberculosis.
    Chen HA; Cheng NC; Lin KP; Liao HT; Chen CH; Huang DF
    J Intern Med; 2005 Jun; 257(6):561-3. PubMed ID: 15910561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antioxidants in the combined therapy of patients with chronic destructive pulmonary tuberculosis].
    Ivanova LA; Pavlova MV; Archakova LI
    Ter Arkh; 1994; 66(11):54-6. PubMed ID: 7900021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hepatoprotective action of total liver extract combined with vitamin B 12 vitamin E, and vitamin K in the course of treatment with multiple mycobacterial agents in patients with tuberculosis with chronic liver disease].
    D'Angelo G; Salatino A
    Clin Ter; 1970 Jan; 52(1):61-70. PubMed ID: 5525554
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of lipid peroxidation product, nitrite and antioxidant levels in newly diagnosed and two months follow-up patients with pulmonary tuberculosis.
    Lamsal M; Gautam N; Bhatta N; Toora BD; Bhattacharya SK; Baral N
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):695-703. PubMed ID: 17883009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lipid peroxidation and antioxidant defence in patients with pneumoconiosis and dust-induced bronchitis].
    Kolodub FA; Kleĭner AI; Makotchenko VM; Kashkalda DA; Martynov PN
    Med Tr Prom Ekol; 1993; (11-12):31-3. PubMed ID: 7921839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of sodium thiosulfate on morphological manifestations of experimental tuberculosis].
    Novoselova VP; Andrzheiuk NI
    Arkh Patol; 1983; 45(6):67-73. PubMed ID: 6625931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Blood serum electrolytes in toxic forms of pulmonary tuberculosis treated with antitubercular and corticosteroid drugs].
    Klawitter M; Kubiaczyk T
    Gruzlica; 1968 Oct; 36(10):1058-61. PubMed ID: 5715458
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the therapy of fibrosis of the lung].
    Zabolay S
    Z Tuberk Erkr Thoraxorg; 1968 Mar; 127(5):291-3. PubMed ID: 5755345
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of antimicrobial chemotherapy and smoking status on the plasma concentrations of vitamin C, vitamin E, beta-carotene, acute phase reactants, iron and lipid peroxides in patients with pulmonary tuberculosis.
    Plit ML; Theron AJ; Fickl H; van Rensburg CE; Pendel S; Anderson R
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):590-6. PubMed ID: 9661828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antihypoxic agents as drugs for pathogenetic therapy of tuberculosis (lecture)].
    Aleksandrova AE
    Probl Tuberk; 1994; (3):47-50. PubMed ID: 7937674
    [No Abstract]   [Full Text] [Related]  

  • 34. Paradoxical ascites during antituberculous chemotherapy.
    Piryani RM; Sijapati MJ; Shrestha S; Dhungana SP; Khakurel S; Acharya GP
    J Coll Physicians Surg Pak; 2013 Apr; 23(4):310. PubMed ID: 23552551
    [No Abstract]   [Full Text] [Related]  

  • 35. [The use of prednisolone in patients with active pulmonary tuberculosis].
    Sergeev IS; Pervova TN; Starostenko EV; Ignatova AV; Noskova GP
    Probl Tuberk; 1969; 47(2):40-5. PubMed ID: 5380562
    [No Abstract]   [Full Text] [Related]  

  • 36. [Real-time polymerase chain reaction in the diagnosis of pulmonary tuberculosis].
    Salina TIu; Morozova TI
    Probl Tuberk Bolezn Legk; 2008; (6):12-4. PubMed ID: 18710048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid peroxidation in autoimmune systemic vasculitides. Effect of corticoid treatment on lipid peroxidation. Antioxidant protection with vitamin E.
    Serban MG; Tănăseanu S
    Rom J Intern Med; 1994; 32(2):137-42. PubMed ID: 7920328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of antioxidant therapy in the complex treatment of patients with pulmonary tuberculosis associated with diabetes mellitus].
    Kravtsova IV
    Probl Tuberk; 1985; (7):33-7. PubMed ID: 4048134
    [No Abstract]   [Full Text] [Related]  

  • 39. [On case of "congenital tuberculosis": clinical considerations and pathogenetic findings].
    Bariffi F; Ripani P; Zeilinger G
    Arch Monaldi; 1971; 26(5):466-77. PubMed ID: 5173328
    [No Abstract]   [Full Text] [Related]  

  • 40. Total antioxidant levels are low during active TB and rise with anti-tuberculosis therapy.
    Wiid I; Seaman T; Hoal EG; Benade AJ; Van Helden PD
    IUBMB Life; 2004 Feb; 56(2):101-6. PubMed ID: 15085934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.